CD8A and ovarian carcinoma: A meta-analysis with almost 4500 patients with mixed or serous histologic subtypes of ovarian cancer showed that intraepithelial CD3+, CD8+, and CD103+ TILs are clearly associated with increased overall survival and disease specific survival, with the location of TILs within the tumour being important for this prognostic effect [7].